Antibiotic resistance of Helicobacter pylori strains in Japanese children

被引:84
作者
Kato, S
Fujimura, S
Udagawa, H
Shimizu, T
Maisawa, S
Ozawa, K
Iinuma, K
机构
[1] Tohoku Univ, Sch Med, Dept Pediat, Aoba Ku, Sendai, Miyagi 9808574, Japan
[2] Miyagi Univ, Dept Microbiol, Miyagi, Japan
[3] Otsuka Tokyo Assay Labs, Tokyo, Japan
[4] Juntendo Univ, Sch Med, Dept Pediat, Tokyo 113, Japan
[5] Morioka Childrens Hosp, Morioka, Iwate, Japan
关键词
D O I
10.1128/JCM.40.2.649-653.2002
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
The resistance of Helicobacter pylori to the recently available antibiotic treatment regimens has been a growing problem. We investigated the prevalence of H. pylori resistance to clarithromycin, metronidazole, and amoxicillin among 51 H. pylori isolates from Japanese children. In addition, the mutations of the corresponding gene were studied by PCR and restriction fragment length polymorphism analysis. Primary resistance to clarithromycin, metronidazole, and amoxicillin was detected in 29, 24, and 0% of strains, respectively. The eradication rates in clarithromycin-susceptible and -resistant strains were 89 and 56%, respectively (P < 0.05). The prevalence of strains with acquired resistance to clarithromycin (78%) was higher than that of strains with primary resistance (P < 0.01). Among the clarithromycin-resistant strains studied, 92% showed cross-resistance to azithromycin. No acquired resistance to amoxicillin was demonstrated. The A2144G mutation in the 23S rRNA gene was detected in 11 of 12 (92%) clarithromycin-resistant strains tested, whereas the mutation was not detected in any of the 15 susceptible strains. The deletion of the rdxA gene was not demonstrated in any of the strains. The results indicate that a high prevalence of clarithromycin-resistant strains is associated with eradication failure. Testing of susceptibility to clarithromycin is recommended.
引用
收藏
页码:649 / 653
页数:5
相关论文
共 34 条
[1]   Primary and acquired Helicobacter pylori resistance to clarithromycin, metronidazole, and amoxicillin -: Influence on treatment outcome [J].
Adamek, RJ ;
Suerbaum, S ;
Pfaffenbach, B ;
Opferkuch, W .
AMERICAN JOURNAL OF GASTROENTEROLOGY, 1998, 93 (03) :386-389
[2]   Features and trends in Helicobacter pylori antibiotic resistance in Lisbon area, Portugal (1990-1999) [J].
Cabrita, J ;
Oleastro, M ;
Matos, R ;
Manhente, A ;
Cabral, J ;
Barros, R ;
Lopes, AI ;
Ramalho, P ;
Neves, BC ;
Guerreiro, AS .
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2000, 46 (06) :1029-1031
[3]  
Chiba N, 1996, AM J GASTROENTEROL, V91, P2139
[4]   Insertion of mini-IS605 and deletion of adjacent sequences in the nitroreductase (rdxA) gene cause metronidazole resistance in Helicobacter pylori NCTC11637 [J].
Debets-Ossenkopp, YJ ;
Pot, RGJ ;
van Westerloo, DJ ;
Goodwin, A ;
Vandenbroucke-Grauls, CMJE ;
Berg, DE ;
Hoffman, PS ;
Kusters, JG .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1999, 43 (11) :2657-2662
[5]   ASSOCIATION OF CAMPYLOBACTER-PYLORI ON THE GASTRIC-MUCOSA WITH ANTRAL GASTRITIS IN CHILDREN [J].
DRUMM, B ;
SHERMAN, P ;
CUTZ, E ;
KARMALI, M .
NEW ENGLAND JOURNAL OF MEDICINE, 1987, 316 (25) :1557-1561
[6]   Mutations in 23S rRNA in Helicobacter pylori conferring resistance to erythromycin do not always confer resistance to clarithromycin [J].
García-Arata, MI ;
Baquero, F ;
de Rafael, L ;
de Argila, CM ;
Gisbert, JP ;
Bermejo, F ;
Boixeda, D ;
Cantón, R .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1999, 43 (02) :374-376
[7]   Use of an amplified-fragment length polymorphism technique to fingerprint and differentiate isolates of Helicobacter pylori [J].
Gibson, JR ;
Slater, E ;
Xerry, J ;
Tompkins, DS ;
Owen, RJ .
JOURNAL OF CLINICAL MICROBIOLOGY, 1998, 36 (09) :2580-2585
[8]  
GLUPCZYNSKI Y, 1990, AM J GASTROENTEROL, V85, P1545
[9]   Metronidazole resistance in Helicobacter pylori is due to null mutations in a gene (rdxA) that encodes an oxygen-insensitive NADPH nitroreductase [J].
Goodwin, A ;
Kersulyte, D ;
Sisson, G ;
van Zanten, SJOV ;
Berg, DE ;
Hoffman, PS .
MOLECULAR MICROBIOLOGY, 1998, 28 (02) :383-393
[10]   Susceptibility of Helicobacter pylori isolates against agents commonly administered for eradication therapy and the efficacy of chemotherapy [J].
Gotoh, A ;
Kawakami, Y ;
Akahane, T ;
Akamatsu, T ;
Shimizu, T ;
Kiyosawa, K ;
Katsuyama, T .
MICROBIOLOGY AND IMMUNOLOGY, 1997, 41 (01) :7-12